Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom.
作者信息
Pawaskar Manjiri, Burgess Colleen, Pillsbury Matthew, Kanibir M Nabi, Platt Heather L
机构信息
Merck & Co, Kenilworth, New Jersey, USA.
MSD, International, Luzern, Switzerland.
出版信息
Clin Infect Dis. 2021 Sep 7;73(5):935-936. doi: 10.1093/cid/ciab040.
Abstract
摘要
相似文献
1
Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom.
Clin Infect Dis. 2021 Sep 7;73(5):935-936. doi: 10.1093/cid/ciab040.
2
The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
Vaccine. 2012 Feb 1;30(6):1225-34. doi: 10.1016/j.vaccine.2011.11.026. Epub 2011 Nov 23.
3
Economic evaluation of Varicella vaccination: results of a systematic review.
Hum Vaccin Immunother. 2013 Sep;9(9):1932-42. doi: 10.4161/hv.25228. Epub 2013 Jul 3.
4
Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.
Southeast Asian J Trop Med Public Health. 2005 Nov;36(6):1450-8.
5
Chickenpox party or varicella vaccine?
Adv Exp Med Biol. 2005;568:11-24. doi: 10.1007/0-387-25342-4_2.
6
Assessing the introduction of universal varicella vaccination in the Netherlands.
Vaccine. 2006 Sep 11;24(37-39):6288-99. doi: 10.1016/j.vaccine.2006.05.071. Epub 2006 Jun 8.
7
Clinical and economic considerations of vaccination against varicella.
Pharmacotherapy. 1997 Jan-Feb;17(1):133-9.
8
The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France.
Vaccine. 1999 Jan;17(2):142-51. doi: 10.1016/s0264-410x(98)00161-3.
9
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom.
Epidemiol Infect. 2001 Oct;127(2):305-14. doi: 10.1017/s0950268801005921.
10
Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
EBioMedicine. 2015 Aug 8;2(10):1494-9. doi: 10.1016/j.ebiom.2015.08.017. eCollection 2015 Oct.
本文引用的文献
1
Epidemiological Impact and Cost-Effectiveness of Varicella Vaccination Strategies in the United Kingdom.
Clin Infect Dis. 2021 Dec 6;73(11):e3617-e3626. doi: 10.1093/cid/ciaa1708.
2
Global Varicella Vaccine Effectiveness: A Meta-analysis.
Pediatrics. 2016 Mar;137(3):e20153741. doi: 10.1542/peds.2015-3741. Epub 2016 Feb 16.
3
Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study.
Pediatrics. 2013 May;131(5):e1389-96. doi: 10.1542/peds.2012-3303. Epub 2013 Apr 1.
4
Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Pediatr Infect Dis J. 2004 Feb;23(2):132-7. doi: 10.1097/01.inf.0000109287.97518.67.
5
Use of statistical models for evaluating antibody response as a correlate of protection against varicella.
Stat Med. 2002 Nov 30;21(22):3411-30. doi: 10.1002/sim.1268.
6
Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.
Pediatr Infect Dis J. 2002 Jun;21(6):555-61. doi: 10.1097/00006454-200206000-00014.
7
Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.
J Pediatr. 2001 Aug;139(2):297-304. doi: 10.1067/mpd.2001.116051.
8
Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989.
Pediatrics. 1991 May;87(5):604-10.
Zotero 插件